Covestor LTD Axonics, Inc. Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Axonics, Inc. stock. As of the latest transaction made, Covestor LTD holds 2,729 shares of AXNX stock, worth $193,704. This represents 0.12% of its overall portfolio holdings.

Number of Shares

2,729

Previous 2,741 0.44%

Holding current value

$193,704

Previous $184,000 3.26%

% of portfolio

0.12%

Previous 0.12%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$67.3 - $69.67 $807 - $836	-12 Reduced 0.44%	2,729 $190,000
Q2 2024 Aug 09, 2024	SELL	$66.47 - $69.65 $6,514 - $6,825	-98 Reduced 3.45%	2,741 $184,000
Q1 2024 May 10, 2024	SELL	$56.67 - $69.36 $13,827 - $16,923	-244 Reduced 7.91%	2,839 $196,000
Q4 2023 Feb 09, 2024	SELL	$49.38 - $63.75 $2,962 - $3,825	-60 Reduced 1.91%	3,083 $192,000
Q3 2023 Nov 13, 2023	BUY	$48.64 - $62.51 $44,311 - $56,946	911 Added 40.82%	3,143 $176,000
Q2 2023 Aug 11, 2023	BUY	$47.99 - $60.21 $46,742 - $58,644	974 Added 77.42%	2,232 $113,000
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $26,089 - $33,400	496 Added 65.09%	1,258 $69,000
Q4 2022 Feb 13, 2023	SELL	$59.56 - $76.6 $5,598 - $7,200	-94 Reduced 10.98%	762 $47,000
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $49,323 - $66,480	851 Added 17020.0%	856 $60,000
Q2 2022 Aug 10, 2022	SELL	$39.5 - $64.42 $39 - $64	-1 Reduced 16.67%	5 $0
Q1 2022 May 13, 2022	SELL	$43.74 - $62.76 $87 - $125	-2 Reduced 25.0%	6 $0
Q4 2021 Feb 10, 2022	BUY	$50.01 - $73.35 $400 - $586	8 New	8 $0

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account